Featured Image


Allows Medical marijuana?: Limited (Yes High-CBD, low-THC oil)

Allows Adult-Use marijuana?: No

2018 Medical Sales : N/A

2022 Projected Medical Sales : N/A

2018 Adult Use Sales : N/A

2022 Projected Adult Use Sales : N/A

Noteworthy Information: Georgia has registry for medical CBD patients, but no system for obtaining cannabis. Only oil is allowed, and it must both: 1) contain no more than .3% THC by weight, and 2) have an amount of CBD equal to or greater than the amount of THC. Patients may possess up to 20 fluid ounces of the oil. The law does not address how low-THC oil is produced, purchased or shipped. The law only creates a procedure to ensure qualified patients will be protected from prosecution for possessing it. The wording of the statute allows patients to only obtain oil through a university, or other research of which the patient is a part.

Is there a Regulatory Structure? (State Agency): No (Georgia Department of Public Health issues registry cards. The Board of Regents of the University System of Georgia oversees what exists.)

# of Dispensaries Allowed (# issued): 0 (Must be involved in a research program being conducted by the Board of Regents of the University System of Georgia, or its authorized agent)

# of Cultivations Allowed (# issued): N/A

# of Manufacturers Allowed (# issued): N/A

# of Testing labs Allowed (# issued): N/A

Geographic Distribution of Licenses: The Board of Regents of the University System of Georgia, or its authorized agent(s), are the only entities allowed

Application Fee: 
N/A [fee for a “Low THC Oil Permit” (Card): $25]

Licensing Fees: 

Residency Requirements: 

Vertical Integration Allowed, Required or Prohibited: 

Medical Marijuana Qualifying Patient Conditions: 
(1) Cancer, when such diagnosis is end stage or the treatment produces related wasting illness or recalcitrant nausea and vomiting 
(2) Amyotrophic lateral sclerosis, when such diagnosis is severe or end stage 
(3) Seizure disorders related to diagnosis of epilepsy or trauma related head injuries 
(4) Multiple sclerosis, when such diagnosis is severe or end stage 
(5) Crohn’s disease 
(6) Mitochondrial disease 
(7) Parkinson’s disease, when such diagnosis is sever or end stage 
(8) Sickle cell disease, when such diagnosis is severe or end stage 
(9) Tourette’s syndrome, when such syndrome is diagnosed as severe 
(10) Autism spectrum disorder, when (a) patient is 18 years of age or more, or (b) patient is less than 18 years of age and diagnosed with severe autism 
(11) Epidermolysis bullosa 
(12) Alzheimer’s disease, when such disease is severe or end stage 
(13) AIDS when such syndrome is severe or end stage 
(14) Peripheral neuropathy, when symptoms are severe or end stage 
(15) Patient is in hospice program, either as inpatient or outpatient 

Effective July 1, 2018:
(16) PTSD
(17) Intractable pain

Testing Required: 
Yes. Amount of THC and CBD must be on label


Please enter your comment!
Please enter your name here